drugset / Trial / NCT00107484
Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer
Phase 2
Completed
3 enrolled
Virginia Commonwealth University
National Cancer Institute (NCI) · collab
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
RATIONALE: Diagnostic procedures, such as magnetic resonance imaging (MRI) using ferumoxtran-10, may help find and diagnose breast cancer that may have spread to the axillary lymph nodes and may help in planning breast cancer treatment. PURPOSE: This phase II trial is studying how well MRI using ferumoxtran-10 works in finding metastases to the axillary lymph nodes in patients with invasive breast cancer.
Timeline
- Start
- 2005-09
- Primary completion
- 2006-10
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferumoxtran-10 | Diagnostic / imaging agent | — | Intravenous |